China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Ultra-low-dose Radiotherapy Combined with Zuberitamab for Limited Stage MALT'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134003
Registration Time: 2026/10/10
Type: Interventional study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344826
Published by HT Digital Content Services with permission from Health Daily Digest....